These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 26840950)

  • 1. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
    Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
    Bonura C; Giuffrè M; Aleo A; Fasciana T; Di Bernardo F; Stampone T; Giammanco A; ; Palma DM; Mammina C
    PLoS One; 2015; 10(7):e0132936. PubMed ID: 26177547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
    Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
    J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Characteristics and
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Mathas C; Merkouri E; Platsouka ED
    Microb Drug Resist; 2020 Jan; 26(1):28-37. PubMed ID: 31386596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Giordano C; Barnini S; Tsioutis C; Chlebowicz MA; Scoulica EV; Gikas A; Rossen JW; Friedrich AW; Bathoorn E
    Int J Antimicrob Agents; 2018 Feb; 51(2):260-265. PubMed ID: 29097338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
    Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D
    J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
    Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.
    Mammina C; Bonura C; Di Bernardo F; Aleo A; Fasciana T; Sodano C; Saporito MA; Verde MS; Tetamo R; Palma DM
    Euro Surveill; 2012 Aug; 17(33):. PubMed ID: 22913977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.
    Mansour W; Haenni M; Saras E; Grami R; Mani Y; Ben Haj Khalifa A; El Atrouss S; Kheder M; Fekih Hassen M; Boujâafar N; Bouallegue O; Madec JY
    J Glob Antimicrob Resist; 2017 Sep; 10():88-94. PubMed ID: 28711559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
    Papadimitriou-Olivgeris M; Bartzavali C; Spyropoulou A; Lambropoulou A; Sioulas N; Vamvakopoulou S; Karpetas G; Spiliopoulou I; Vrettos T; Anastassiou ED; Fligou F; Christofidou M; Marangos M
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):235-240. PubMed ID: 30076041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010.
    Zagorianou A; Sianou E; Iosifidis E; Dimou V; Protonotariou E; Miyakis S; Roilides E; Sofianou D
    Euro Surveill; 2012 Feb; 17(7):. PubMed ID: 22370015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.
    Lalaoui R; Bakour S; Livnat K; Assous MV; Diene SM; Rolain JM
    Microb Drug Resist; 2019; 25(1):63-71. PubMed ID: 30129868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital.
    Battikh H; Harchay C; Dekhili A; Khazar K; Kechrid F; Zribi M; Masmoudi A; Fendri C
    Microb Drug Resist; 2017 Jun; 23(4):468-472. PubMed ID: 27802107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological and molecular characterization of extreme drug-resistant carbapenemase-producing Klebsiella pneumoniae isolates.
    Santino I; Bono S; Nuccitelli A; Martinelli D; Petrucci C; Alari A
    Int J Immunopathol Pharmacol; 2013; 26(3):785-90. PubMed ID: 24067478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
    Ocampo AM; Chen L; Cienfuegos AV; Roncancio G; Chavda KD; Kreiswirth BN; Jiménez JN
    Antimicrob Agents Chemother; 2016 Jan; 60(1):332-42. PubMed ID: 26503660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.
    Papadimitriou-Olivgeris M; Bartzavali C; Lambropoulou A; Solomou A; Tsiata E; Anastassiou ED; Fligou F; Marangos M; Spiliopoulou I; Christofidou M
    J Antimicrob Chemother; 2019 Jul; 74(7):2051-2054. PubMed ID: 31002313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.